- ISIN
- US00752P1049
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- IPO Date
- Mar 6, 2025
Highlights
- Market Cap
- $8.66M
- Enterprise Value
- $6.05M
- EPS (TTM)
- $0.41
- PE Ratio
- 19.37
- Gross Profit (TTM)
- -$2.55K
- EBITDA (TTM)
- -$1.38M
- Year Range
- $3.61 - $24.23
- ROA (TTM)
- 55.98%
- ROE (TTM)
- 64.71%
- Avg. Volume (1M)
- 5M
- Avg. Volume Value (1M)
- $55.04M
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
ADVB Performance Chart
Advanced Biomed Inc (ADVB) is up 37.1% since the beginning of the year. At $8 per share, ADVB is trading 67.0% below its 52-week high of $24.
Loading charts...
Compare this symbol against anything
Returns By Period
Advanced Biomed Inc (ADVB) has returned 37.08% so far this year and -6.41% over the past 12 months.
Advanced Biomed Inc
- 1D
- -20.63%
- 1M
- 60.32%
- 6M
- 32.49%
- YTD
- 37.08%
- 1Y
- -6.41%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- -80.65%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
ADVB Monthly Returns History
Based on dividend-adjusted daily data since Mar 6, 2025, ADVB's average daily return is -0.21%, while the average monthly return is -8.53%.
Historically, 35% of months were positive and 65% were negative. The best month was Jul 2026 with a return of +72.1%, while the worst month was Apr 2025 at -51.0%. The longest winning streak lasted 2 consecutive months, and the longest losing streak was 6 months.
On a daily basis, ADVB closed higher 45% of trading days. The best single day was Jul 20, 2026 with a return of +76.9%, while the worst single day was Apr 8, 2025 at -37.6%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 3.46% | -32.72% | 12.25% | 17.32% | -6.36% | -7.19% | 72.05% | 37.08% | |||||
| 2025 | -2.00% | -51.01% | -46.38% | -32.03% | -33.94% | -8.87% | 6.34% | 7.25% | -12.59% | -30.54% | -92.70% |
Benchmark Metrics
Advanced Biomed Inc has an annualized alpha of -44.96%, beta of 0.37, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since March 06, 2025.
- This stock participated in 420.40% of S&P 500 Index downside but only -145.33% of its upside - more exposed to losses than it benefited from rallies.
- Beta of 0.37 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -44.96%
- Beta
- 0.37
- R²
- 0.00
- Upside Capture
- -145.33%
- Downside Capture
- 420.40%
Return for Risk
Risk / Return Rank
ADVB ranks 49 for risk / return — above 49% of stocks peers on PortfoliosLab. Its historical combined result is near the middle of the peer group.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for Advanced Biomed Inc (ADVB) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ADVB | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.50 | ||
| Sortino ratioReturn per unit of downside risk | -0.75 | ||
| Omega ratioGain probability vs. loss probability | 1.15 | 1.25 | -0.10 |
| Calmar ratioReturn relative to maximum drawdown | -0.20 | 2.00 | -2.20 |
| Martin ratioReturn relative to average drawdown | -0.31 | 8.49 | -8.80 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Advanced Biomed Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Advanced Biomed Inc was 95.36%, occurring on Jun 9, 2026. The portfolio has not yet recovered.
The current Advanced Biomed Inc drawdown is 90.00%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-95.36%Jun 2026 | 1y 3mo | — | 1y 5moMar 2025 - now | — |
Drawdown Indicators
| ADVB | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.36% | -56.78% | -38.58% |
Max Drawdown (1Y)Largest decline over 1 year | -67.29% | -9.10% | -58.19% |
Max Drawdown (3Y)Largest decline over 3 years | — | -18.90% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -90.00% | -1.58% | -88.42% |
Average DrawdownAverage peak-to-trough decline | -81.61% | -10.70% | -70.91% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 43.76% | 2.14% | +41.62% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Advanced Biomed Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Advanced Biomed Inc is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for ADVB, comparing it with other companies in the Diagnostics & Research industry. Currently, ADVB has a P/E ratio of 19.4. This P/E ratio is considered low compared to industry peers, which may suggest that the stock is undervalued or that the company has weaker growth prospects.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with ADVB
Add Advanced Biomed Inc to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with ADVB